Skip to Main Content

Diabetes Research at Yale

Studies of Type 1 and Type 2 Diabetes, in addition to Obesity and Weight Management
For decades, Yale University has been committed to better understanding the causes and treatment of diabetes. From the first successful studies of insulin pump technology in the 1970s, to current investigations directed at understanding the cellular mechanisms underlying Type 2 diabetes and the immunologic basis of Type 1 diabetes, Yale is at the forefront of diabetes research. Clinician-scientists at Yale University School of Medicine have received numerous grants from the National Institutes of Health (NIH), the American Diabetes Association and the Juvenile Diabetes Research Foundation (JDRF) to support ongoing innovative and cutting-edge research in diabetes and metabolic disorders.

Like many discoveries, the development of the first insulin pump was a combination of ingenuity and teamwork. In 1979, Dr. Robert Sherwin and Dr. William Tamborlane developed the insulin pump to treat Type 1 diabetes. Today, it’s used by more than 350,000 diabetic patients and its popularity continues to grow. Without volunteers like the children and their families who were willing to participate in clinical research, this groundbreaking discovery would not have been possible.

Yale’s tradition of discovery continues through research to improve our understanding of diabetes and obesity, including prevention, causes and better treatments – but we can’t do any of this without you! By participating in a research study, you are not only able to help others in the future, but you may gain access to new treatments before they are widely available and could be the first to benefit from such treatments. You are also able to obtain care from specialists at a leading healthcare facility while participating in a study.

We are currently recruiting volunteers ages 18-85 with overweight, obesity, and Type 1 and Type 2 diabetes. Healthy volunteers are also needed.
Compensation up to $800.

Please call (203) 737-4777 or email for more information.

Stopping Diabetes Before It Starts

Claire Wirt, now 9, has been participating in a clinical trial for most of her life. She and her brother take part in TrialNet, an international study that aims to prevent, delay, and reverse the progression of type 1 diabetes.